{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:49:52Z","timestamp":1791236992377,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-49","type":"journal-article","created":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T01:14:10Z","timestamp":1330564450000},"source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant Tuberculosis in Viet Nam"],"prefix":"10.1186","volume":"12","author":[{"given":"Dang Thi","family":"Minh Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Ngoc Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Wolbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo sy","family":"Kiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Thi","family":"Thanh Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Hong","family":"Duc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"To My","family":"Huong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuong Minh","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Phuong Thao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Van","family":"Quyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Bich Tuyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Thi","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai Viet","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Thi","family":"Hoang Anh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Huy","family":"Dung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Caws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"1883_CR1","volume-title":"Multidrug and extensively drug-resistant TB (M\/XDR-TB). 2010 Global report on serveillance and response. WHO\/HTM\/TB\/2010.3","author":"World Health Organisation","year":"2010","unstructured":"World Health Organisation: Multidrug and extensively drug-resistant TB (M\/XDR-TB). 2010 Global report on serveillance and response. WHO\/HTM\/TB\/2010.3. 2010, Available at:. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599191_eng.pdf . Accessed March 25, 2011"},{"issue":"9728","key":"1883_CR2","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/S0140-6736(10)60410-2","volume":"375","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J: Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010, 375 (9728): 1830-1843. 10.1016\/S0140-6736(10)60410-2.","journal-title":"Lancet"},{"key":"1883_CR3","volume-title":"Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings","author":"World Health Organisation","year":"2007","unstructured":"World Health Organisation: Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. 2007, WHO\/HTM\/TB\/2007.379. Available at: http:\/\/whqlibdoc.who.int\/hq\/2007\/WHO_HTM_TB_2007.379_eng.pdf . Accessed July 8, 2010"},{"key":"1883_CR4","volume-title":"Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report of the seventh meeting","author":"World Health Organisation","year":"2007","unstructured":"World Health Organisation: Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report of the seventh meeting. 2007, Available at: http:\/\/www.who.int\/tb\/events\/stag_report_2007.pdf . Accessed January 11, 2011"},{"key":"1883_CR5","volume-title":"New laboratory diagnostic: Tools for Tuberculosis control","author":"World Health Organisation","year":"2008","unstructured":"World Health Organisation: New laboratory diagnostic: Tools for Tuberculosis control. 2008, http:\/\/www.who.int\/tdr\/publications\/documents\/diagnostic-tool-tb.pdf Accessed April 18, 2010"},{"key":"1883_CR6","volume-title":"Non-commercial culture and drug-susceptibility testing methods for screening of patients at risk of multi-drug resistant tuberculosis-Policy statement","author":"World Health Organisation","year":"2010","unstructured":"World Health Organisation: Non-commercial culture and drug-susceptibility testing methods for screening of patients at risk of multi-drug resistant tuberculosis-Policy statement. 2010, Available at: http:\/\/www.stoptb.org\/wg\/gli\/assets\/documents\/WHO%20Policy%20Statement%20on%20Non-commercial%20Culture%20and%20DST%20Methods%20FINAL%20March%202010.pdf . Accessed January 10, 2011"},{"issue":"8","key":"1883_CR7","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1128\/JCM.37.8.2607-2618.1999","volume":"37","author":"K Kremer","year":"1999","unstructured":"Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martin C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, et al: Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999, 37 (8): 2607-2618.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1883_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S1473-3099(10)70165-1","volume":"10","author":"J Minion","year":"2010","unstructured":"Minion J, Leung E, Menzies D, Pai M: Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10 (10): 688-698. 10.1016\/S1473-3099(10)70165-1.","journal-title":"Lancet Infect Dis"},{"key":"1883_CR9","volume-title":"Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report of the ninth meeting","author":"World Health Organisation","year":"2009","unstructured":"World Health Organisation: Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Report of the ninth meeting. 2009, Available at: http:\/\/www.who.int\/tb\/advisory_bodies\/stag_tb_report_2009.pdf . Accessed January 10, 2011"},{"key":"1883_CR10","volume-title":"Molecular line probe assay for rapid screening of patients at risk of multidrug-resistant. (MDR-TB). Policy Statement","author":"World Health Organisation","year":"2008","unstructured":"World Health Organisation: Molecular line probe assay for rapid screening of patients at risk of multidrug-resistant. (MDR-TB). Policy Statement. 2008, Available at: http:\/\/www.who.int\/tb\/dots\/laboratory\/lpa_policy.pdf . Accessed June 12, 2010"},{"issue":"11","key":"1883_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","volume":"363","author":"CC Boehme","year":"2010","unstructured":"Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al: Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010, 363 (11): 1005-1015. 10.1056\/NEJMoa0907847.","journal-title":"N Engl J Med"},{"issue":"7","key":"1883_CR12","doi-asserted-by":"publisher","first-page":"e1001061","DOI":"10.1371\/journal.pmed.1001061","volume":"8","author":"LE Scott","year":"2011","unstructured":"Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W: Comparison of Xpert MTB\/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med. 2011, 8 (7): e1001061-10.1371\/journal.pmed.1001061.","journal-title":"PLoS Med"},{"key":"1883_CR13","volume-title":"Roadmap for rolling out Xpert MTB\/RIF for rapid diagnosis of TB and MDR-TB","author":"World Health Organisation","year":"2010","unstructured":"World Health Organisation: Roadmap for rolling out Xpert MTB\/RIF for rapid diagnosis of TB and MDR-TB. 2010, Available at: http:\/\/www.who.int\/tb\/laboratory\/roadmap_xpert_mtb-rif.pdf . Accessed March 29, 2011"},{"issue":"3","key":"1883_CR14","first-page":"332","volume":"12","author":"GS Ejigu","year":"2008","unstructured":"Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E: Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008, 12 (3): 332-337.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"15","key":"1883_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa055524","volume":"355","author":"DA Moore","year":"2006","unstructured":"Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al: Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006, 355 (15): 1539-1550. 10.1056\/NEJMoa055524.","journal-title":"N Engl J Med"},{"issue":"10","key":"1883_CR16","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1128\/JCM.42.10.4432-4437.2004","volume":"42","author":"DA Moore","year":"2004","unstructured":"Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, et al: Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004, 42 (10): 4432-4437. 10.1128\/JCM.42.10.4432-4437.2004.","journal-title":"J Clin Microbiol"},{"key":"1883_CR17","unstructured":"Moore D: MODS quality assurance. Available at: http:\/\/www.modsperu.org\/MODS_QA.pdf . Accessed September 15, 2008. 2007"},{"issue":"9729","key":"1883_CR18","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/S0140-6736(10)60359-5","volume":"375","author":"RS Wallis","year":"2010","unstructured":"Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375 (9729): 1920-1937. 10.1016\/S0140-6736(10)60359-5.","journal-title":"Lancet"},{"issue":"10","key":"1883_CR19","first-page":"1463","volume":"13","author":"NB Tran","year":"2007","unstructured":"Tran NB, Houben RM, Hoang TQ, Nguyen TN, Borgdorff MW, Cobelens FG: HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002. Emerg Infect Dis. 2007, 13 (10): 1463-1469.","journal-title":"Emerg Infect Dis"},{"key":"1883_CR20","unstructured":"World Health Organisation: Global Tuberculosis Control. Epidemiology, strategy and financing (update). Available at: http:\/\/www.who.int\/tb\/publications\/global_report\/2009\/update\/tbu_9.pdf . Accessed March 3, 2010"},{"key":"1883_CR21","unstructured":"World Health Organisation: Global tuberculosis control and patient care. A ministerial meeting of high M\/XDR-TB burden countries. Beijing, China, 1-3 April 2009. Available at: http:\/\/www.who.int\/tb_beijingmeeting\/country_level\/mdrtb_wprcountryprofile2007_vtn.pdf . Accessed July 7, 2010. In"},{"issue":"12","key":"1883_CR22","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/JCM.00687-10","volume":"48","author":"DT Ha","year":"2010","unstructured":"Ha DT, Lan NT, Kiet VS, Wolbers M, Hang HT, Day J, Hien NQ, Tien NA, An PT, Anh TT, et al: Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol. 2010, 48 (12): 4573-4579. 10.1128\/JCM.00687-10.","journal-title":"J Clin Microbiol"},{"key":"1883_CR23","volume-title":"Laboratory brocedure. BBL\u2122 MGIT\u2122 Mycobacteria Growth Indicator Tube 7 mL supplemented with BACTEC\u2122 MGIT\u2122 Growth Supplement, BBL\u2122 MGIT\u2122 PANTA\u2122 Antibiotic Mixture","author":"Beckton Dickinson","year":"2005","unstructured":"Dickinson Beckton: Laboratory brocedure. BBL\u2122 MGIT\u2122 Mycobacteria Growth Indicator Tube 7 mL supplemented with BACTEC\u2122 MGIT\u2122 Growth Supplement, BBL\u2122 MGIT\u2122 PANTA\u2122 Antibiotic Mixture. 2005, Available at: http:\/\/www.bd.com\/ds\/technicalCenter\/inserts\/L000180JAA%28201106%29.pdf . Accessed Feb 7, 2011"},{"issue":"12","key":"1883_CR24","doi-asserted-by":"publisher","first-page":"e8341","DOI":"10.1371\/journal.pone.0008341","volume":"4","author":"DT Ha","year":"2009","unstructured":"Ha DT, Lan NT, Wolbers M, Duong TN, Quang ND, Thi Van Thinh T, Thi Hong Ngoc L, Thi Ngoc Anh N, Van Quyet T, Thi Bich Tuyen N, et al: Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One. 2009, 4 (12): e8341-10.1371\/journal.pone.0008341.","journal-title":"PLoS One"},{"issue":"6","key":"1883_CR25","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1128\/JCM.41.6.2323-2329.2003","volume":"41","author":"S Honore-Bouakline","year":"2003","unstructured":"Honore-Bouakline S, Vincensini JP, Giacuzzo V, Lagrange PH, Herrmann JL: Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol. 2003, 41 (6): 2323-2329. 10.1128\/JCM.41.6.2323-2329.2003.","journal-title":"J Clin Microbiol"},{"key":"1883_CR26","volume-title":"Guidelines for surveillence of drug resistance in tuberculosis. WHO\/TB\/2003.320-WHO\/CDS\/CSR\/RMD\/2003.3","author":"World Health Organisation","year":"2003","unstructured":"World Health Organisation: Guidelines for surveillence of drug resistance in tuberculosis. WHO\/TB\/2003.320-WHO\/CDS\/CSR\/RMD\/2003.3. 2003, Available at: http:\/\/whqlibdoc.who.int\/publications\/2003\/9241546336.pdf . Accessed March 22, 2011"},{"issue":"11","key":"1883_CR27","first-page":"1306","volume":"12","author":"DQ Tho","year":"2008","unstructured":"Tho DQ, Ha DT, Duy PM, Lan NT, Hoa DV, Chau NV, Farrar J, Caws M: Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008, 12 (11): 1306-1312.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"1883_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5588\/ijtld.10.0599","volume":"15","author":"DQ Tho","year":"2011","unstructured":"Tho DQ, Lan NT, Chau NV, Farrar J, Caws M: Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2011, 15 (6): 799-803. 10.5588\/ijtld.10.0599.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"1883_CR29","first-page":"1320","volume":"13","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Yew WW: Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009, 13 (11): 1320-1330.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1883_CR30","unstructured":"Jorge Coronel MR, Luz Caviedes, David Moore: MODS - A USER GUIDE - Microscopic Observation drug Susceptibility Assay. v12.114082008. Available at http:\/\/www.modsperu.org\/MODS_user_guide.pdf . Accessed Jan 13 rd 2009, vol. v12.114082008. Lima - Peru; 2008"},{"issue":"Pt 11","key":"1883_CR31","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1099\/jmm.0.46718-0","volume":"55","author":"H Guo","year":"2006","unstructured":"Guo H, Seet Q, Denkin S, Parsons L, Zhang Y: Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol. 2006, 55 (Pt 11): 1527-1531.","journal-title":"J Med Microbiol"},{"issue":"10","key":"1883_CR32","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1128\/JCM.00580-07","volume":"45","author":"FC Mello","year":"2007","unstructured":"Mello FC, Arias MS, Rosales S, Marsico AG, Pavon A, Alvarado-Galvez C, Pessoa CL, Perez M, Andrade MK, Kritski AL, et al: Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007, 45 (10): 3387-3389. 10.1128\/JCM.00580-07.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-49\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-49","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T12:54:37Z","timestamp":1593780877000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1883"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-49","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]},"article-number":"49"}}